NCT02625519View on ClinicalTrials.gov

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

PHASE4UnknownINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

March 31, 2019

Conditions
Reproductive Techniques, Assisted
Interventions
DRUG

Urinary follicle-stimulating hormone

Ovarian stimulation with highly purified urinary follicle-stimulating hormone

DRUG

Recombinant follicle-stimulating hormone

Controled ovarian stimulation with recombinant follicle-stimulating hormone

Trial Locations (1)

03016

RECRUITING

Instituto Bernabeu, Alicante

Sponsors

Lead Sponsor

Instituto Bernabeu
All Listed Sponsors
lead

Instituto Bernabeu

OTHER

NCT02625519 - Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) | Biotech Hunter | Biotech Hunter